Since up-regulated expression of LINK-A in vivo is regulated by gene amplification and disease-related SNPs, researchers are beginning to focus on the effects of LINK-A SNPs on the development of drug resistance in cancer patients. This evidence concerns the gene LINC01139 and cancer.